Perfluorooctane Sulfonate and Perfluorooctanoic Acid in the Fingernails of Urban and Rural Children

Chinese Science Bulletin

Volumn 55, Issue 33, 2010, Pages 3755-3762

  Xu, Lei ^a   Liu, Wei ^a   Jin, Yi He ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

biomarker; environmental exposure; fingernails; perfluorooctane sulfonate; perfluorooctanoic acid

Indexed keywords

EID: 78650010362     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-010-4156-6     Document Type: Article

References (50)

1. Lau C, Anitole K, Hodes C, et al. Perfluoroalkyl acids: A review of monitoring and toxicological findings. Toxicol Sci, 2007, 99: 366-394.
2. Prevedouros K, Cousins I T, Buck R C, et al. Sources, fate and transport of perfluorocarboxylates. Environ Sci Technol, 2006, 40: 32-44.
3. Volkel W, Genzel-Boroviczeny O, Demmelmair H, et al. Perfluorooctane sulphonate (PFOS) and perfluoro octanoic acid (PFOA) in human breast milk: Results of a pilot study. Int J Hyg Environ Health, 2008, 211: 440-446.
4. Giesy J P, Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol, 2001, 35: 1339-1342.
5. Smithwick M, Mabury S A, Solomon K R, et al. Circumpolar study of perfluoroalkyl contaminants in polar bears (Ursus maritimus). Environ Sci Technol, 2005, 39: 5517-5523.
6. Tomy G T, Budakowski W R, Halldorson T, et al. Fluorinated organic compounds in an eastern arctic marine food web. Environ Sci Technol, 2004, 38: 6475-6481.
7. 3M Company. Environmental and Health Assessment of Perfluorooctane Sulfonic Acid and Its Salts. U. S. Environmental Protection Agency Public Docket, 2003. AR 226-1486.
8. Kennedy G L, Butenhoff J L, Olsen G W, et al. The toxicology of perfluorooctanoate. Crit Rev Toxicol, 2004, 34: 351-384.
9. OECD (Organisation for Economic Co-operation and Development). Results of survey on production and use of PFOS, PFAS and PFOA, relates substances and products/mixtures containing these substances. ENV/JM/MONO (2005)1. 2005.
10. Yeung L W, So M K, Jiang G, et al. Perfluorooctanesulfonate and related fluorochemicals in human blood samples from China. Environ Sci Technol, 2006, 40: 715-720.
11. David T, Lea H, Matthias W, et al. Estimating Consumer Exposure to PFOS and PFOA. Risk Analysis, 2008, 28: 251-269.
12. Wang Y, Yeung L W Y, Yamashita N, et al. Perfluorooctane sulfonate (PFOS) and related fluorochemicals in chicken egg in China. Chinese Sci Bull, 2008, 53: 501-507.
13. Wang J M, Shi Y L, Pan Y Y, et al. Perfluorinated compounds in milk, milk powder and yoghurt purchased from markets in China. Chinese Sci Bull, 2010, 55: 1020-1025.
14. Wilhelm M, Holzer J, Dobler L, et al. Preliminary observations on perfluorinated compounds in plasma samples (1977-2004) of young German adults from an area with perfluorooctanoate-contaminated drinking water. Int J Hyg Environ Health, 2009, 212: 142-145.
15. Liu W, Dong G H, Jin Y H, et al. Occurrence of perfluoroalkyl acids in precipitation from Shenyang, China. Chinese Sci Bull, 2009, 54: 2440-2445.
16. Thibodeaux J R, Hanson R G, Rogers J M, et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I. Maternal and prenatal evaluations. Toxicol Sci, 2003, 74: 369-381.
17. Abbott B D, Wolf C J, Das K P, et al. Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse. Reprod Toxicol, 2009, 27: 258-265.
18. Peden-Adams M M, Keller J M, Eudaly J G, et al. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci, 2008, 104: 144-154.
19. Abdellatif A G, Preat V, Taper H S, et al. The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator. Toxicol Appl Pharmacol, 1991, 111: 530-537.
20. Case M T, York R G, Christian M S. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int J Toxicol, 2001, 20: 101-109.
21. 3M Company. Health and Environmental Assessment of Perfluorooctane Sulfonic Acid and Its Salts. U. S. EPA docket AR-226-1486. Washington, DC: U. S. Environmental Protection Agency, 2003.
22. OECD (Organization for Economic Co-operation and Development). Co-operation on existing chemicals. Hazard assessment of perfluorooctane sulfonate (PFOS) and its salts, ENV/JM/RD(2002)17/FINAL, Paris, 2002.
23. Seacat A M, Thomford P J, Butenhoff J L. Terminal observations in Sprague-Dawley rats after lifetime dietary exposure to potassium perfluorooctanesulfonate [Abstract]. Toxicologist, 2002a, 66: 185.
24. Seacat A M, Thomford P J, Hansen K J, et al. Subchronic dietary toxicity of potassium perfluorooctane sulfonate in rats. Toxicology, 2003, 183: 117-131.
25. Seacat A M, Thomford P J, Hansen K J, et al. Subchronic toxicity studies on perfluorooctane sulfonate potassium salt in cynomolgus monkeys. Toxicol Sci, 2002b, 68: 249-264.
26. Austin M E, Kasturi B S, Barber M, et al. Neuroendocrine effects of perfluorooctane sulfonate in rats. Environ Health Perspect, 2003, 111: 1485-1489.
27. Inoue K, Okada F, Ito R, et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: Assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect, 2004, 112: 1204-1207.
28. Apelberg B J, Goldman L R, Calafat A M, et al. Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ Sci Technol, 2007, 41: 3891-3897.
29. Tao L, Kannan K, Wong C M, et al. Perfluorinated compounds in human milk from Massachusetts, U. S. A. Environ Sci Technol, 2008, 42: 3096-3101.
30. Toms L M, Calafat A M, Kato K, et al. Polyfluoroalkyl Chemicals in Pooled Blood Serum from Infants, Children, and Adults in Australia. Environ Sci Technol, 2009, 43: 4194-4199.
31. Olsen G W, Church T R, Hansen K J, et al. Quantitative evaluation of perfluorooctane sulfonate (PFOS) and other fluorochemicals in the serum of children. J Child Health, 2004, 2: 53-76.
32. Kato K, Calafat A M, Wong L Y, et al. Polyfluoroalkyl compounds in pooled sera from children participating in the National Health and Nutrition Examination Survey 2001-2002. Environ Sci Technol, 2009, 43: 2641-2647.
33. Wilhelm M, Angerer J, Fromme H, et al. Contribution to the evaluation of reference values for PFOA and PFOS in plasma of children and adults from Germany. Int J Hyg Environ Health, 2009, 212: 56-60.
34. Ehresman D J, Froehlich J W, Olsen G W, et al. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ Res, 2007, 103: 176-184.
35. Harada K, Koizumi A, Saito N, et al. Historical and geographical aspects of the increasing perfluorooctanoate and perfluorooctane sulfonate contamination in human serum in Japan. Chemosphere, 2007, 66: 293-301.
36. Karrman A, Mueller J F, Bavel B V, et al. Levels of 12 perfluorinated chemicals in pooled australian serum, collected 2002-2003, in relation to age, gender, and region. Environ Sci Technol, 2006, 40: 3742-3748.
37. Midasch O, Schettgen T, Angerera J. Pilot study on the perfluorooctane-sulfonate and perfluorooctanoate exposure of the German general population. Int J Hyg Environ Health, 2006, 209: 489-496.
38. Fromme H, Midasch O, Twardella D, et al. Occurrence of perfluorinated substances in an adult German population in southern Bavaria. Int Arch Occup Environ Health, 2007, 80: 313-319.
39. Inoue K, Okada F, Ito R, et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: Assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect, 2004, 112: 1204-1207.
40. So M K, Yamashita N, Taniyasu S, et al. Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China. Environ Sci Technol, 2006, 40: 2924-2929.
41. Karrman A, Ericson I, van Bavel B, et al. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect, 2007, 115: 226-230.
42. Guruge K S, Taniyasu S, Yamashita N, et al. Perfluorinated organic compounds in human blood serum and seminal plasma: A study of urban and rural tea worker populations in Sri Lanka. J Environ Monit, 2005, 7: 371-377.
43. Bean W B. Nail growth. Thirty-five years of observation. Arch Intern Med, 1980, 140: 73-76.
44. Liu J, Li J, Luan Y, et al. Geographical Distribution of Perfluorinated Compounds in Human Blood from Liaoning Province, China. Environ Sci Technol, 2009, 43: 4044-4048.
45. Calafat A M, Kuklenyik Z, Caudill S P, et al. Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. Environ Sci Technol, 2006, 40: 2128-21.
46. Jin Y H, Liu X, Zhang X, et al. Perfluorooctane sulfonate situation in serum of common population (in Chinese). Chin J Public Health, 2003, 19: 1200-1201.
47. Bjorklund J A, Thuresson K, De W C. Perfluoroalkyl Compounds (PFCs) in Indoor Dust: Concentrations, Human Exposure Estimates, and Sources. Environ Sci Technol, 2009, 43: 2276-2281.
48. Liu X H, Liu B, Jin Y H. Effect of perfluorooctane sulfonate on intracellular free calcium level in rats' hippocampus. China Environ Sci, 2010, 30: 110-115.
49. Yu W G, Liu W, Jin Y H. Effects of subchronic perfluorooctane sulfonate exposure of rats on calcium-dependent signaling molecules in the brain tissue. Environ Toxicol Chem, 2009, 28: 990-996.
50. Sasaki K, Harada K, Saito N, et al. Impact of airborne perfluorooctane sulfonate on the human body burden and the ecological system. Bull Environ Contam Toxicol, 2003, 71: 408-413.